Modify Your Treatment: Switch or Augment the Citalopram
Given persistent depressive symptoms on citalopram 40 mg and atomoxetine 80 mg daily, you should modify your antidepressant treatment within the next 1-2 weeks, as you have not achieved adequate response after what appears to be a sufficient trial. 1
Immediate Next Steps
The American College of Physicians guideline is clear: modify treatment if inadequate response occurs within 6-8 weeks of initiating therapy for major depressive disorder 1. Since you're already on the maximum recommended dose of citalopram (40 mg/day—higher doses risk QT prolongation and cardiac complications 2, 3), you have two evidence-based options:
Option 1: Augmentation Strategy (Preferred Initial Approach)
Add bupropion SR to your current citalopram regimen 4. The landmark STAR*D trial found that augmenting an SSRI with bupropion SR was equally effective as other augmentation strategies, with the key advantage of lower discontinuation rates due to adverse events (12.5%) compared to buspirone (20.6%) 4.
Why bupropion specifically for you:
- Addresses residual depressive symptoms effectively 4
- Lower rates of sexual dysfunction compared to SSRIs alone 1
- May provide additional benefit for ADHD symptoms alongside your atomoxetine 5, 6
- Well-tolerated in combination with atomoxetine 5
Dosing: Start bupropion SR 150 mg daily, increase to 150 mg twice daily after 3-7 days as tolerated
Option 2: Switch Strategy (If Augmentation Fails or Not Tolerated)
Switch from citalopram to a different second-generation antidepressant 1, 4. Evidence shows no single agent is superior, but consider:
- Venlafaxine XR or duloxetine (SNRIs): May provide additional noradrenergic benefit complementing your atomoxetine 4
- Escitalopram: Similar mechanism but some patients respond differently 4
- Mirtazapine: Different mechanism, may help if insomnia or appetite issues present 4
The 2023 ACP systematic review found no significant differences in efficacy between various switch strategies (bupropion SR, escitalopram, duloxetine, sertraline, venlafaxine XR) 4.
Critical Safety Considerations
Citalopram at Maximum Dose
You're already at the FDA maximum of 40 mg/day—exceeding this risks QT prolongation, Torsade de Pointes, ventricular tachycardia, and sudden death 2, 3. Do not increase citalopram further.
Atomoxetine Combination Issues
- Atomoxetine + duloxetine: Exercise extreme caution—there's a case report of takotsubo cardiomyopathy in an adolescent with this combination 7. If switching to duloxetine, monitor cardiovascular parameters closely
- Atomoxetine + bupropion: Generally well-tolerated based on available evidence 5, 6
- Your atomoxetine 80 mg daily is appropriate and may already be helping anxiety symptoms 8, 9
What About Your Comorbidities?
GAD Component
Your atomoxetine is likely providing some benefit for anxiety—studies show it reduces anxiety symptoms in ADHD patients with comorbid anxiety 8, 9. The citalopram should also be addressing GAD, but persistent symptoms suggest inadequate response.
ADHD Component
Continue atomoxetine 80 mg daily. Evidence supports atomoxetine as effective for ADHD with comorbid mood/anxiety disorders 5, 10, 9, 11. If ADHD symptoms remain problematic after addressing depression, consider adding/switching to methylphenidate 6.
Monitoring Timeline
- Week 1-2: Assess tolerability of new medication (augmentation or switch)
- Week 4-6: Evaluate early response—some improvement should be evident
- Week 8-12: Full assessment of efficacy; if inadequate, consider third-step strategies 1, 4
If First Modification Fails
Consider:
- Cognitive behavioral therapy (CBT) as augmentation or switch—STAR*D showed similar efficacy to medication augmentation with potentially fewer adverse events 4
- Aripiprazole augmentation: One trial showed higher remission rates (55.4% vs 34% with bupropion augmentation), though this was a smaller study 4
- Referral to psychiatry for consideration of other strategies
Common Pitfalls to Avoid
- Don't increase citalopram above 40 mg—cardiac risk outweighs any potential benefit 2, 3
- Don't stop citalopram abruptly—risk of discontinuation syndrome (dizziness, nausea, electric shock sensations) 2, 3
- Don't assume atomoxetine is ineffective—it takes 6-12 weeks for full effect and helps both ADHD and anxiety 12, 9
- Monitor for suicidality closely during any medication changes, especially in first 1-2 months 1, 3
Bottom line: Start bupropion SR augmentation now, reassess in 4-6 weeks, and don't wait longer than 8 weeks total before making another change if response remains inadequate.